Synercid

Synercid is a brand name of dalfopristin/quinupristin, approved by the FDA in the following formulation(s):

SYNERCID (dalfopristin; quinupristin - injectable; iv (infusion))

• 
  Manufacturer: KING PHARMS
  
  Approval date: September 21, 1999
  
  Strength(s): 350MG/VIAL;150MG/VIAL ^[RLD]

Has a generic version of Synercid been approved?

No. There is currently no therapeutically equivalent version of Synercid available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Synercid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Synercid.

See also...

• Synercid Consumer Information (Wolters Kluwer)
• Synercid Consumer Information (Cerner Multum)
• Synercid Advanced Consumer Information (Micromedex)
• Quinupristin/Dalfopristin Consumer Information (Wolters Kluwer)
• Dalfopristin and quinupristin Consumer Information (Cerner Multum)
• Quinupristin and dalfopristin Intravenous Advanced Consumer Information (Micromedex)
• Quinupristin and Dalfopristin AHFS DI Monographs (ASHP)